SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    MacGregor AJ, Canavan R, Knight C, Denton CP, Davar J, Coghlan J, et al. Pulmonary hypertension in systemic sclerosis: risk factors for progression and consequences for survival. Rheumatology (Oxford) 2001; 40: 4539.
  • 2
    Steen V, Medsger TA Jr. Predictors of isolated pulmonary hypertension in patients with systemic sclerosis and limited cutaneous involvement. Arthritis Rheum 2003; 48: 51622.
  • 3
    Koh ET, Lee P, Gladman DD, Abu-Shakra M. Pulmonary hypertension in systemic sclerosis: an analysis of 17 patients. Br J Rheumatol 1996; 35: 98993.
  • 4
    Kawut SM, Taichman DB, Archer-Chicko CL, Palevsky HI, Kimmel SE. Hemodynamics and survival in patients with pulmonary arterial hypertension related to systemic sclerosis. Chest 2003; 123: 34450.
  • 5
    Sanchez O, Humbert M, Sitbon O, Nunes H, Garcia G, Simonneau G. Hypertension artérielle pulmonaire associée aux connectivites. Rev Med Interne 2002; 23: 4154.
  • 6
    British Cardiac Society Guidelines and Medical Practice Committee recommendations on the management of pulmonary hypertension in clinical practice. Heart 2001; 86 Suppl 1: 113.
  • 7
    Murata I, Kihara H, Shinohara S, Ito K. Echocardiographic evaluation of pulmonary arterial hypertension in patients with progressive systemic sclerosis and related syndromes. Jpn Circ J 1992; 56: 98391.
  • 8
    Mukerjee D, St George D, Knight C, Davar J, Wells AU, du Bois RM, et al. Echocardiography and pulmonary function as screening tests for pulmonary arterial hypertension in systemic sclerosis. Rheumatology (Oxford) 2004; 43: 4616.
  • 9
    Battle RW, Davitt MA, Cooper SM, Buckley LM, Leib ES, Beglin PA, et al. Prevalence of pulmonary hypertension in limited and diffuse scleroderma. Chest 1996; 110: 15159.
  • 10
    Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980; 23: 58190.
  • 11
    LeRoy EC, Black C, Fleischmager R, Jablonska S, Krieg T, Medsger TA Jr. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 1988; 1: 2025.
  • 12
    Simonneau G, Galie N, Rubin LJ, Langleben D, Seeger W, Domenighetti G, et al. Clinical classification of pulmonary hypertension. J Am Coll Cardiol 2004; 43: 5S12S.
  • 13
    Clements PJ, Lachenbruch PA, Seibold JR, Zee B, Steen VD, Brennan P, et al. Skin thickness score in systemic sclerosis: an assessment of interobserver variability in 3 independent studies. J Rheumatol 1993; 20: 18926.
  • 14
    Berger M, Haimowitz A, van Tosh A, Berdoff R, Goldberg E. Quantitative assessment of pulmonary hypertension in patients with tricuspid regurgitation using continuous wave Doppler ultrasound. J Am Coll Cardiol 1985; 6: 35965.
  • 15
    Kessler R, Faller M, Weitzenblum E, Chaouat A, Ayrut A, Ducolone A, et al. “Natural history” of pulmonary hypertension in a series of 131 patients with chronic obstructive lung disease. Am J Respir Crit Care Med 2001; 164: 21924.
  • 16
    Atwood CW, McCrory D, Garcia JG, Abman SH, Ahearn GS. Pulmonary artery hypertension and sleep-disordered breathing: ACCP evidence-based clinical practice guidelines. Chest 2004; 126: 72S7S.
  • 17
    Ungerer RG, Tashkin DP, Furst D, Clements PJ, Gong H Jr, Bein M, et al. Prevalence and clinical correlates of pulmonary arterial hypertension in progressive systemic sclerosis. Am J Med 1983; 75: 6574.
  • 18
    Mukerjee D, St George D, Coleiro B, Knight C, Denton CP, Davar J, et al. Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approach. Ann Rheum Dis 2003; 62: 108893.
  • 19
    Launay D, Hachulla E, Hatron PY, Michon-Pasturel U, Hebbar M, Queyrel V, et al. Dépistage de l'hypertension artérielle pulmonaire au cours de la sclérodermie systémique: étude d'une cohorte de 67 patients. Rev Med Interne 2001; 22: 81929.
  • 20
    Le Guern V, Mahr A, Mouthon L, Jeanneret D, Carzon M, Guillevin L. Prevalence of scleroderma in a French multi-ethnic county. Rheumatology (Oxford) 2004; 43: 112937.
  • 21
    Borgeson D, Seward J, Miller FJ, Oh J, Tajik A. Frequency of Doppler measurable pulmonary artery pressures. J Am Soc Echocardiogr 1996; 9: 8327.
  • 22
    McGoon M, Gutterman D, Steen V, Barst R, McCrory DC, Fortin TA, et al. Screening, early detection and diagnosis of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. Chest 2004; 126: 14S34S.
  • 23
    Barst RJ, McGoon M, Torbicki A, Sitbon O, Krowka M, Olschewski H, et al. Diagnosis and differential assessment of pulmonary arterial hypertension. J Am Coll Cardiol 2004; 43: 40S7S.
  • 24
    McQuillan B, Picard M, Leawitt M, Weyman A. Clinical correlates and reference intervals for pulmonary artery systolic pressure among echocardiographically normal subjects. Circulation 2001; 104: 2797802.
  • 25
    Murata I, Takenaka K, Yoshinoya S, Kikuchi K, Kiuchi T, Tanigawa T, et al. Clinical evaluation of pulmonary hypertension in systemic sclerosis and related disorders: a Doppler echocardiographic study of 135 Japanese patients. Chest 1997; 111: 3643.
  • 26
    Guillinta P, Peterson KL, Ben-Yehuda O. Cardiac catheterization techniques in pulmonary hypertension. Cardiol Clin 2004; 22: 40115.
  • 27
    Galie N, Seeger W, Naeije R, Simonneau G, Rubin LJ. Comparative analysis of clinical trials and evidence-based treatment algorithm in pulmonary arterial hypertension. J Am Coll Cardiol 2004; 43: 81S8S.
  • 28
    Badesch DB, Abman SH, Ahearn GS, Barst RJ, McCrory DC, Simonneau G, et al. Medical therapy for pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. Chest 2004; 126: 35S62S.
  • 29
    Humbert M, Sitbon O, Simonneau G. Treatment of pulmonary arterial hypertension. N Engl J Med 2004; 351: 142536.